GYRE COO exercises options, sells 28,680 shares
GYRE THERAPEUTICS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
GYRE THERAPEUTICS, INC. Chief Operating Officer Weiguo Ye reported a small exercise-and-sell pattern over two days. On May 14 and 15, 2026, he exercised stock options to acquire a total of 28,680 shares of common stock at $0.75 per share and sold the same number of shares in open-market transactions, at weighted average prices of $6.91 and $6.65, respectively, across multiple trades.
After these transactions, Ye directly owns 700,000 shares of common stock. All options involved were fully vested, and the sales were executed across price ranges disclosed through weighted-average pricing footnotes.
Insider Trade Summary
Exercise and Sale: 28,680 shares ($173K approx. pre-tax spread)
Exercise and Sale
6 txns
Insider
Ye Weiguo
Role
Chief Operating Officer
Sold
28,680 shs ($195K)
Approx. gross sale proceeds
$195K
Approx. exercise cost
$22K
Approx. pre-tax spread
$173K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 13,100 | $0.00 | $0.00 |
| Exercise | Common Stock | 13,100 | $0.75 | $10K |
| Sale | Common Stock | 13,100 | $6.65 | $87K |
| Exercise | Stock Option (Right to Buy) | 15,580 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,580 | $0.75 | $12K |
| Sale | Common Stock | 15,580 | $6.91 | $108K |
Holdings After Transaction:
Stock Option (Right to Buy) — 936,435 contracts (Direct);
Common Stock — 700,000 shares (Direct)
Footnotes (3)
- F1. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.8326 to $7.28. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F2. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.58 to $6.85. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3. These options are vested in full.
Key Figures
Shares sold: 28,680 shares
Options exercised: 28,680 shares
Exercise price: $0.75 per share
+4 more
7 metrics
Shares sold
28,680 shares
Total open-market sales on May 14–15, 2026
Options exercised
28,680 shares
Total shares acquired via option exercise
Exercise price
$0.75 per share
Stock option exercise price for common stock
Weighted average sale price (May 14)
$6.91 per share
15,580 shares sold, prices from $6.8326 to $7.28
Weighted average sale price (May 15)
$6.65 per share
13,100 shares sold, prices from $6.58 to $6.85
Post-transaction holdings
700,000 shares
Common stock directly owned after transactions
Option expiration
October 31, 2030
Expiration date for exercised stock options
Key Terms
open-market sale, derivative security, weighted average sale price, Stock Option (Right to Buy), +1 more
5 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average sale price financial
"The price reported represents the weighted average sale price per share."
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
vested in full financial
"These options are vested in full."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did GYRE COO Weiguo Ye report on this Form 4?
Weiguo Ye reported option exercises and related share sales. He exercised stock options for 28,680 GYRE common shares at $0.75 and sold the same number of shares in open-market trades on May 14 and 15, 2026, at weighted average prices above $6.50.
What was the option exercise price for Weiguo Ye’s GYRE stock options?
The exercised GYRE stock options had a $0.75 exercise price. On both May 14 and 15, 2026, Ye exercised fully vested stock options to acquire 15,580 and 13,100 common shares, respectively, each at $0.75 per share before selling the acquired stock.
Were GYRE COO Weiguo Ye’s stock options fully vested before exercise?
Yes, the exercised GYRE stock options were fully vested. A Form 4 footnote states that the options exercised on May 14 and 15, 2026 are “vested in full,” indicating they were completely earned and exercisable at the time of the transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates